y 27632 has been researched along with cardiovascular agents in 2 studies
| Studies (y 27632) | Trials (y 27632) | Recent Studies (post-2010) (y 27632) | Studies (cardiovascular agents) | Trials (cardiovascular agents) | Recent Studies (post-2010) (cardiovascular agents) |
|---|---|---|---|---|---|
| 1,924 | 3 | 891 | 17,645 | 1,480 | 6,891 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kass, DA; McKinsey, TA | 1 |
| Ding, H; Du, Y; Li, X; Sun, W; Zeng, Y; Zhao, H; Zhao, L; Zhao, S | 1 |
1 review(s) available for y 27632 and cardiovascular agents
| Article | Year |
|---|---|
Small-molecule therapies for cardiac hypertrophy: moving beneath the cell surface.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Amides; Animals; Cardiomegaly; Cardiovascular Agents; Humans; Models, Biological; Molecular Structure; Pyridines; Receptors, Cell Surface; Signal Transduction | 2007 |
1 other study(ies) available for y 27632 and cardiovascular agents
| Article | Year |
|---|---|
Microengineered in vitro model of cardiac fibrosis through modulating myofibroblast mechanotransduction.
Topics: Amides; Animals; Cardiovascular Agents; Cell Proliferation; Cells, Cultured; Drug Discovery; Fibrosis; Heart Diseases; Male; Mechanotransduction, Cellular; Mice; Models, Cardiovascular; Myofibroblasts; NIH 3T3 Cells; Pyridines; Rats, Sprague-Dawley | 2014 |